Insole Optimisation for Ulcer Prevention: a Feasibility Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01948479
Recruitment Status : Unknown
Verified September 2013 by Joanne Paton, University of Plymouth.
Recruitment status was:  Not yet recruiting
First Posted : September 23, 2013
Last Update Posted : September 26, 2013
University Hospital Plymouth NHS Trust
Information provided by (Responsible Party):
Joanne Paton, University of Plymouth

Brief Summary:

Insoles are designed to reduce increased loads and re-ulceration risk in patients with diabetes. The investigators previous research findings suggest that an instant insole solution may benefit some, but effectiveness is difficult to predict. The investigators propose a feasibility study using in-shoe pressure analysis to optimise the protective effect of insoles and footwear with the aim of reducing re-ulceration rates.

Early indications from exploratory case studies within the real world clinical setting suggest that by implementing the investigators previous published research findings the investigators can optimise effectiveness and reduce outcome variability of protective footwear and insoles provided to patients at risk of re-ulceration.

However a further randomised control trial is necessary to evaluate the effectiveness of in-shoe pressure analysis in reducing re-ulceration rates within the NHS setting. The proposed feasibility study will recruit 20 participants from the multidisaplinary diabetic foot clinic Derriford Hospital and allocate them to either 1) Routine insoles and footwear provision or 2) Routine insole and footwear provision, and temporary insole provision with optimisation. The findings from the feasibility study will inform protocol development for a larger clinical trial. The results of the feasibility study will be used to strengthen a protocol for a grant application to conduct the main RCT. A secondary output from the pilot study will be the dissemination of findings in a peer reviewed journal and at conference.

Condition or disease Intervention/treatment Phase
Diabetic Neuropathic Past Ulceration Device: Optimised instant offloading insole Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Prevention of Foot Ulcer Recurrence in People With Diabetes Using an In-shoe Pressure Measurement Technology: A Randomised Control Trial Feasibility Study
Study Start Date : January 2014
Estimated Primary Completion Date : January 2015
Estimated Study Completion Date : January 2015

Arm Intervention/treatment
Experimental: Insole optimised with inshoe analysis Device: Optimised instant offloading insole
Active Comparator: Routine insole provision Device: Optimised instant offloading insole

Primary Outcome Measures :
  1. ulcer recurrence rates [ Time Frame: 6 months ]

Secondary Outcome Measures :
  1. peak pressure reduction with the addition of the intervention [ Time Frame: Issue and 6 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   30 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, aged 30 years or above
  • Diagnosed with Diabetes Mellitus
  • Recently healed/healing target ulcer on the weight-bearing surface of the foot
  • Neuropathic (Mild to moderate DPN defined as insensitivity of a 10 g monofilament at 1-3 sites in the following locations: hallux, 1st, 3rd, and 5th metatarsal heads (Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, Lavery LA, Lemaster JW, Mills JL Sr, Mueller MJ, Sheehan P, Wukich DK: Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 2008;31:1679-1685)
  • Able (in the Investigators opinion) and willing to comply with all study requirements

Exclusion Criteria:

  • The participant may not enter the study if ANY of the following apply: Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.
  • None healing foot ulcer at another site that requires targeted off-loading.
  • Unable to walk 5 metres with/without walking aid
  • Peripheral vascular disease (non-re-constructible vascular disease as determined by arterial duplex and clinically assessed by a vascular consultant)
  • Unwilling to wear therapeutic footwear
  • Where amputation has been part of the current episode of care and includes ulceration site.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01948479

Contact: Joanne Paton, PhD 01752 588845

United Kingdom
Derriford Hospital Not yet recruiting
Plymouth, Devon, United Kingdom, PL6 8BH
Contact: Graham Bruce   
Sub-Investigator: Graham Bruce         
Sponsors and Collaborators
University of Plymouth
University Hospital Plymouth NHS Trust

Additional Information:
Responsible Party: Joanne Paton, NIHR Clinical Research Fellow, University of Plymouth Identifier: NCT01948479     History of Changes
Other Study ID Numbers: PatonRCT02
First Posted: September 23, 2013    Key Record Dates
Last Update Posted: September 26, 2013
Last Verified: September 2013